Johnston Dayle, Earley Bernadette, McCabe Matthew S, Kim Jaewoo, Taylor Jeremy F, Lemon Ken, McMenamy Michael, Duffy Catherine, Cosby S Louise, Waters Sinéad M
Animal and Bioscience Research Department, Animal and Grassland Research and Innovation Centre, Teagasc, Grange, Ireland.
Division of Animal Sciences, University of Missouri, Columbia, MO, United States.
Front Genet. 2021 Apr 22;12:633125. doi: 10.3389/fgene.2021.633125. eCollection 2021.
Bovine respiratory disease (BRD) causes substantial morbidity and mortality, affecting cattle of all ages. One of the main causes of BRD is an initial inflammatory response to bovine respiratory syncytial virus (BRSV). MicroRNAs are novel and emerging non-coding small RNAs that regulate many biological processes and are implicated in various inflammatory diseases. The objective of the present study was to elucidate the changes in the bovine bronchial lymph node miRNA transcriptome in response to BRSV following an experimental viral challenge. Holstein-Friesian calves were either administered a challenge dose of BRSV (10 TCID/ml × 15 ml) ( = 12) or were mock inoculated with sterile phosphate buffered saline ( = 6). Daily scoring of clinical signs was performed and calves were euthanized at day 7 post-challenge. Bronchial lymph nodes were collected for subsequent RNA extraction and sequencing (75 bp). Read counts for known miRNAs were generated using the miRDeep2 package using the UMD3.1 reference genome and the bovine mature miRNA sequences from the miRBase database (release 22). EdgeR was used for differential expression analysis and Targetscan was used to identify target genes for the differentially expressed (DE) miRNAs. Target genes were examined for enriched pathways and gene ontologies using Ingenuity Pathway Analysis (Qiagen). Multi-dimensional scaling (MDS) based on miRNA gene expression changes, revealed a clearly defined separation between the BRSV challenged and control calves, although the clinical manifestation of disease was only mild. One hundred and nineteen DE miRNAs ( < 0.05, FDR < 0.1, fold change > 1.5) were detected between the BRSV challenged and control calves. The DE miRNAs were predicted to target 465 genes which were previously found to be DE in bronchial lymph node tissue, between these BRSV challenged and control calves. Of the DE predicted target genes, 455 had fold changes that were inverse to the corresponding DE miRNAs. There were eight enriched pathways among the DE predicted target genes with inverse fold changes to their corresponding DE miRNA including: granulocyte and agranulocyte adhesion and diapedesis, interferon signalling and role of pathogen recognition receptors in recognition of bacteria and viruses. Functions predicted to be increased included: T cell response, apoptosis of leukocytes, immune response of cells and stimulation of cells. Pathogen recognition and proliferation of cytotoxic T cells are vital for the recognition of the virus and its subsequent elimination.
牛呼吸道疾病(BRD)会导致较高的发病率和死亡率,影响各个年龄段的牛。BRD的主要病因之一是对牛呼吸道合胞病毒(BRSV)的初始炎症反应。微小RNA是一类新出现的非编码小RNA,可调节多种生物学过程,并与各种炎症性疾病有关。本研究的目的是阐明实验性病毒攻击后,牛支气管淋巴结微小RNA转录组对BRSV的反应变化。给荷斯坦-弗里生犊牛接种BRSV攻击剂量(10 TCID/ml×15 ml)(n = 12),或用无菌磷酸盐缓冲盐水进行 mock 接种(n = 6)。每天对临床症状进行评分,并在攻击后第7天对犊牛实施安乐死。收集支气管淋巴结用于后续的RNA提取和测序(75 bp)。使用miRDeep2软件包,以UMD3.1参考基因组和miRBase数据库(版本22)中的牛成熟微小RNA序列,生成已知微小RNA的读数计数。使用EdgeR进行差异表达分析,并用Targetscan鉴定差异表达(DE)微小RNA的靶基因。使用Ingenuity Pathway Analysis(Qiagen)检查靶基因的富集途径和基因本体。基于微小RNA基因表达变化的多维标度(MDS)显示,尽管疾病的临床表现仅为轻度,但BRSV攻击组和对照组犊牛之间有明确的区分。在BRSV攻击组和对照组犊牛之间,检测到119个差异表达微小RNA(P < 0.05,FDR < 0.1,倍数变化> 1.5)。预测这些差异表达微小RNA靶向465个基因,这些基因先前在这些BRSV攻击组和对照组犊牛的支气管淋巴结组织中被发现存在差异表达。在预测的差异表达靶基因中,455个基因的倍数变化与其相应的差异表达微小RNA相反。在预测的差异表达靶基因中,有8条富集途径的倍数变化与其相应的差异表达微小RNA相反,包括:粒细胞和无粒细胞的粘附与渗出、干扰素信号传导以及病原体识别受体在识别细菌和病毒中的作用。预测功能增加的包括:T细胞反应、白细胞凋亡、细胞免疫反应和细胞刺激。病原体识别和细胞毒性T细胞的增殖对于识别病毒及其随后的清除至关重要。